Industry Growth Insights published a new data on “IBS-C Drugs Market”. The research report is titled “IBS-C Drugs Market research by Types (Linaclotide, Lubiprostone, Osmotic Laxatives, Stimulant Laxatives, Others), By Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, Catalent Pharmaceuticals Solutions, Ferring BV, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals Ltd, Norgine B.V, Prometheus Laboratories Inc, Actavis Nordic A/S, Albireo Pharma Inc, Yuhan Corp, Astrazeneca Plc, The Menarini Group, Ono Pharmaceutical Co., Ltd”.
Scope Of The Report
Report Attributes
Report Details
Report Title
IBS-C Drugs Market Research Report
By Type
Linaclotide, Lubiprostone, Osmotic Laxatives, Stimulant Laxatives, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, Catalent Pharmaceuticals Solutions, Ferring BV, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals Ltd, Norgine B.V, Prometheus Laboratories Inc, Actavis Nordic A/S, Albireo Pharma Inc, Yuhan Corp, Astrazeneca Plc, The Menarini Group, Ono Pharmaceutical Co., Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global IBS-C Drugs Market Report Segments:
The global IBS-C Drugs market is segmented on the basis of:
Types
Linaclotide, Lubiprostone, Osmotic Laxatives, Stimulant Laxatives, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Catalent Pharmaceuticals Solutions
- Nestle
- Abbott Laboratories
- Synergy Pharmaceuticals
- Sucampo Pharmaceuticals
- Novartis Pharma Ag
- Astellas Pharmaceuticals
- Ardelyx, Inc
- Synthetic Biologics, Inc
- Teva Pharmaceutical Industries
- Catalent Pharmaceuticals Solutions
- Ferring BV
- Ironwood Pharmaceuticals, Inc
- Salix Pharmaceuticals Ltd
- Norgine B.V
- Prometheus Laboratories Inc
- Actavis Nordic A/S
- Albireo Pharma Inc
- Yuhan Corp
- Astrazeneca Plc
- The Menarini Group
- Ono Pharmaceutical Co., Ltd
Highlights of The IBS-C Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Linaclotide
- Lubiprostone
- Osmotic Laxatives
- Stimulant Laxatives
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IBS-C Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IBS-C drugs are medications used to treat the symptoms of irritable bowel syndrome (IBS). These drugs include antidepressants, antidiarrheals, and pain relievers.
Some of the key players operating in the ibs-c drugs market are Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, Catalent Pharmaceuticals Solutions, Ferring BV, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals Ltd, Norgine B.V, Prometheus Laboratories Inc, Actavis Nordic A/S, Albireo Pharma Inc, Yuhan Corp, Astrazeneca Plc, The Menarini Group, Ono Pharmaceutical Co., Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IBS-C Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 IBS-C Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 IBS-C Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the IBS-C Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global IBS-C Drugs Market Size & Forecast, 2018-2028
4.5.1 IBS-C Drugs Market Size and Y-o-Y Growth
4.5.2 IBS-C Drugs Market Absolute $ Opportunity
Chapter 5 Global IBS-C Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 IBS-C Drugs Market Size Forecast by Type
5.2.1 Linaclotide
5.2.2 Lubiprostone
5.2.3 Osmotic Laxatives
5.2.4 Stimulant Laxatives
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global IBS-C Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 IBS-C Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IBS-C Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IBS-C Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America IBS-C Drugs Analysis and Forecast
9.1 Introduction
9.2 North America IBS-C Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America IBS-C Drugs Market Size Forecast by Type
9.6.1 Linaclotide
9.6.2 Lubiprostone
9.6.3 Osmotic Laxatives
9.6.4 Stimulant Laxatives
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America IBS-C Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe IBS-C Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe IBS-C Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe IBS-C Drugs Market Size Forecast by Type
10.6.1 Linaclotide
10.6.2 Lubiprostone
10.6.3 Osmotic Laxatives
10.6.4 Stimulant Laxatives
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe IBS-C Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific IBS-C Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific IBS-C Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific IBS-C Drugs Market Size Forecast by Type
11.6.1 Linaclotide
11.6.2 Lubiprostone
11.6.3 Osmotic Laxatives
11.6.4 Stimulant Laxatives
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific IBS-C Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America IBS-C Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America IBS-C Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America IBS-C Drugs Market Size Forecast by Type
12.6.1 Linaclotide
12.6.2 Lubiprostone
12.6.3 Osmotic Laxatives
12.6.4 Stimulant Laxatives
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America IBS-C Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) IBS-C Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) IBS-C Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) IBS-C Drugs Market Size Forecast by Type
13.6.1 Linaclotide
13.6.2 Lubiprostone
13.6.3 Osmotic Laxatives
13.6.4 Stimulant Laxatives
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) IBS-C Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IBS-C Drugs Market: Competitive Dashboard
14.2 Global IBS-C Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Catalent Pharmaceuticals Solutions
14.3.2 Nestle
14.3.3 Abbott Laboratories
14.3.4 Synergy Pharmaceuticals
14.3.5 Sucampo Pharmaceuticals
14.3.6 Novartis Pharma Ag
14.3.7 Astellas Pharmaceuticals
14.3.8 Ardelyx, Inc
14.3.9 Synthetic Biologics, Inc
14.3.10 Teva Pharmaceutical Industries
14.3.11 Catalent Pharmaceuticals Solutions
14.3.12 Ferring BV
14.3.13 Ironwood Pharmaceuticals, Inc
14.3.14 Salix Pharmaceuticals Ltd
14.3.15 Norgine B.V
14.3.16 Prometheus Laboratories Inc
14.3.17 Actavis Nordic A/S
14.3.18 Albireo Pharma Inc
14.3.19 Yuhan Corp
14.3.20 Astrazeneca Plc
14.3.21 The Menarini Group
14.3.22 Ono Pharmaceutical Co., Ltd
